120 related articles for article (PubMed ID: 9109299)
1. Immunohistochemical demonstration with anti-bromodeoxyuridine monoclonal antibody in experimental meningeal carcinomatosis model.
Huang TY; Hwang SL; Howng SL
Kaohsiung J Med Sci; 1997 Mar; 13(3):136-40. PubMed ID: 9109299
[TBL] [Abstract][Full Text] [Related]
2. [Growth activity of meningeal carcinomatosis--immunohistochemical study using anti-BrdU monoclonal antibody].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Huang TY; Kuroda R; Mogami H
No To Shinkei; 1988 Feb; 40(2):127-31. PubMed ID: 3370164
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal ACNU against experimental leptomeningeal tumors.
Huang TY; Howng SL
Kaohsiung J Med Sci; 1997 Oct; 13(10):626-30. PubMed ID: 9385779
[TBL] [Abstract][Full Text] [Related]
4. [Effect of ACNU against experimental brain tumor--immunohistochemical study using anti-BrdU monoclonal antibody].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Tzuu-Yuan H; Nagatani M; Oku Y; Mogami H
No To Shinkei; 1988 Nov; 40(11):1095-9. PubMed ID: 3219244
[TBL] [Abstract][Full Text] [Related]
5. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
[TBL] [Abstract][Full Text] [Related]
6. [Postnatal cell proliferation in the rat cerebrum: immunohistochemical study with bromodeoxyuridine (BrdU)].
Fujita T; Yoshimine T; Hayakawa T; Ushio Y; Takemoto O; Maruno M; Kano M; Mogami H
No To Shinkei; 1988 Jul; 40(7):651-5. PubMed ID: 3066383
[TBL] [Abstract][Full Text] [Related]
7. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Davis RL
Cancer; 1986 Oct; 58(7):1466-72. PubMed ID: 2427189
[TBL] [Abstract][Full Text] [Related]
8. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
Nagashima T; Hoshino T
No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
[TBL] [Abstract][Full Text] [Related]
9. [A study on tongue cancer cell labeling using bromodeoxyuridine (BrdU) incorporation in vitro].
Li X; Zhao Q; He R; Zhou X; Chen W
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Oct; 19(5):278-80. PubMed ID: 12539478
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
11. [A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
Nagashima T; Hoshino T
No To Shinkei; 1985 Dec; 37(12):1195-201. PubMed ID: 3912000
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue.
Birner P; Ritzi M; Musahl C; Knippers R; Gerdes J; Voigtländer T; Budka H; Hainfellner JA
Am J Pathol; 2001 Jun; 158(6):1991-6. PubMed ID: 11395376
[TBL] [Abstract][Full Text] [Related]
13. [Astrocytic proliferation in the brain adjacent to infarcted lesion: immunohistochemical study of astroprotein (GFAP) and bromodeoxyuridine (BrdU)].
Takemoto O; Yoshimine T; Hayakawa T; Fujita T; Nakajima S; Taneda M; Mogami H
No To Shinkei; 1989 Apr; 41(4):361-5. PubMed ID: 2765300
[TBL] [Abstract][Full Text] [Related]
14. Growth activity of tumors at different intracranial structures: immunohistochemical study with bromodeoxyuridine.
Yoshimine T; Ushio Y; Hayakawa T; Takemoto O; Maruno M; Mogami H
Acta Neuropathol; 1986; 71(1-2):15-8. PubMed ID: 3776468
[TBL] [Abstract][Full Text] [Related]
15. In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Lee SS; Lee TS; Park JS; Cho EK; Chung CH
J Korean Med Sci; 1989 Dec; 4(4):193-201. PubMed ID: 2639694
[TBL] [Abstract][Full Text] [Related]
16. Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination.
Fukui M; Iwaki T; Sawa H; Inoue T; Takeshita I; Kitamura K
Acta Neurochir (Wien); 1986; 81(3-4):135-41. PubMed ID: 3529838
[TBL] [Abstract][Full Text] [Related]
17. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
18. [Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the analysis of tumor cell kinetics by flow cytometry].
Kanno M; Takeda Y; Nakamura S
Nihon Rinsho; 1992 Oct; 50(10):2333-7. PubMed ID: 1280304
[TBL] [Abstract][Full Text] [Related]
19. The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
Nagashima T; Hoshino T; Cho KG; Edwards MS; Hudgins RJ; Davis RL
Cancer; 1988 Jun; 61(12):2433-8. PubMed ID: 3284636
[TBL] [Abstract][Full Text] [Related]
20. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]